Hashimoto thyroiditis may be associated with a subset of patients with systemic sclerosis with pulmonary hypertension

Revista Brasileira de Reumatologia

Volumn 54, Issue 5, 2014, Pages 366-370

  Costa, Ciliana Cardoso B ^a   Medeiros, Morgana ^a   Watanabe, Karen ^b   Martin, Patricia ^a   Skare, Thelma L ^a  

^a HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^b FACULDADE EVANGÉLICA DO PARANÁ   (Brazil)

Author keywords

Hashimoto thyroiditis; Pulmonary hypertension; Scleroderma; Systemic sclerosis

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MYOSITIS; NECROSIS; PREVALENCE; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SCAR; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; COMPLICATION; HYPERTENSION, PULMONARY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HASHIMOTO DISEASE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 85016497825     PISSN: 04825004     EISSN: 18094570     Source Type: Journal    
DOI: 10.1016/j.rbre.2014.04.001     Document Type: Article

References (28)

1. Nancy AL, Yehuda S. Prediction and prevention ofautoimmune disorders. Arch Dermatol Res. 2009;301:57-64.
2. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. NEngl J Med. 1996;335:99-107.
3. Allanore Y, Avouac J, Kahan A. Systemic sclerosis: an updatein 2008. Joint Bone Spine. 2008;75:650-5.
4. Avouac J, Airò P, Dieude P, Caramaschi P, Tiev K, Diot E, et al. Associated autoimmune diseases in systemic sclerosis definea subset of patients with milder disease: results from 2 largecohorts of European Caucasian patients. J Rheumatol. 2010;37:608-14.
5. Hu PQ, Fertig N, Medsger Jr TA, Wright TM. Correlation ofserum anti-DNA topoisomerase I antibody levels with diseaseseverity and activity in systemic sclerosis. Arthritis Rheum. 2003;48:1363-73.
6. Kuwana M, Kaburaki J, Mimori T, Kawakami Y, Tojo T. Longitudinal analysis of autoantibody response totopoisomerase I in systemic sclerosis. Arthritis Rheum. 2000;43:1074-84.
7. Molteni M, Barili M, Eisera N, Scrofani S, Mascagni B, Zulian C, et al. Anti-thyroid antibodies in Italian scleroderma patients:association of anti-thyroid peroxidase (anti-TPO) antibodieswith HLA-DR15. Clin Exp Rheumatol. 1997;15:529-34.
8. Elhai M, Avouac J, Kahan A, Allanore Y. Systemic sclerosis atthe crossroad of polyautoimmunity. Autoimmun Rev. 2013;12:1052-7.
9. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemicsclerosis: an American College of Rheumatology/Europeanleague against rheumatism collaborative initiative. AnnRheum Dis. 2013;72:1747-55.
10. Clements PJ, Lachenbruch P. Siebold. Inter and Intraobsevervariability of total skin thickness score (modified Rodnan TSS)in systemic sclerosis. J Rheumatol. 1995;22:1281-5.
11. Poormoghim H, Lucas M, Fertig N, Medsger Jr TA. Systemicsclerosis sine scleroderma: demographic, clinical, andserologic features and survival in forty-eight patients. Arthritis Rheum. 2000;43:444-51.
12. Behr J, Furst DE. Pulmonary function tests. Rheumatology. 2008;47:65-7.
13. Wells AU. High-resolution computed tomography andscleroderma lung disease. Rheumatology. 2008;47:59-61.
14. Medsger Jr TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis:development and testing. J Rheumatol. 1999;26:2159-67.
15. Robazzi TCMV, Adan LF. Autoimmune thyroid disease onpatients with rheumatic diseases. Rev Bras Reumatol. 2012;52:417-30.
16. Pearce EN, Farwell AP, Braveman M. Thyroiditis. N Eng J Med. 2003;348:2647-55.
17. Sweeney L, Voelker NF. Estrogen exposure, obesity andthyroid disease in severe pulmonary hypertension. Eur J MedRes. 2009;14:433-42.
18. Chu JW, Kao PN, Faul JL, Doyle RL. High prevalence ofautoimmune thyroid disease in pulmonary arterialhypertensiom. Chest. 2002;122:1668-73.
19. Curnock A, Raed M, Higgins B, Hussein S, Arroliga AC. Highprevalence of hypothyroidism in patients with primaryhypertension. Am J Med Sci. 1999;318:289-92.
20. Opravil M, Pechere M, Speich R, Joller-Jemelka H, Jenni R, RussiEW, et al. HIV-associated primary pulmonary hypertension: acase control study. Am J Respir Crit Care Med. 1997;155:990-5.
21. Badesch DB, Wynne KM, Bonvallet S, Voelker NF, Ridgway C, Groves BM. Hypothyroidism and primary pulmonaryhypertension: an autoimmune pathogenic link? Ann InternMed. 1993;119:44-6.
22. Lateiwish AM, Feher J, Baraczka K, Rácz K, Kiss R, Gláz E. Remission of Raynaud's phenomenon after L-thyroxinetherapy in a patient with hypothyroidism. J Endocrinol Invest. 1992;15:49-51.
23. Lam HC, Wang JP, Lee JK, Ho LT, Han TM, Chiang HT, et al. Tissue contents of endothelin vary according to thyroidhormone status in rat. J Cardiovasc Pharmacol. 1993;22:S299-302.
24. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increasedplasma endothelin-1 in pulmonary hypertension: marker ormediator of disease? Ann Intern Med. 1991;114:464-9.
25. Balbir-Gurman A, Braun-Moscovici Y. Scleroderma-newaspects in pathogenesis and treatment. Best Pract Res ClinRheumatol. 2012;26:13-24.
26. Silva DR, Gazzana MB, John AB, Siqueira DR, Maia AL, BarretoSS. Pulmonary arterial hypertension and thyroid disease. JBras Pneumol. 2009;35:179-85.
27. Hashizume T, Numata H, Matsushita K. Interstitialpneumonia associated with chronic thyroiditis. NihonKokyuki Gakkai Zasshi. 2002;40:31-4.
28. Khardori R, Eagleton LE, Soler NG, McConnachie PR. Lymphocytic interstitial pneumonitis in autoimmune thyroiddisease. Am J Med. 1991;90:649-52.